ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Newbury Street Acquisition Corporation

Newbury Street Acquisition Corporation (NBSTW)

0.08
0.00
(0.00%)
Cerrado 05 Enero 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.08
Postura de Compra
0.0351
Postura de Venta
0.05
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.08
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
6,625,408
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
744.52
Beneficio por acción (BPA)
0.01
turnover
-
Beneficio neto
97k

Acerca de Newbury Street Acquisition Corporation

Newbury Street Acquisition Corp is a blank check company. Newbury Street Acquisition Corp is a blank check company.

Sector
Blank Checks
Industria
Blank Checks
Sede
Wilmington, Delaware, USA
Fundado
-

NBSTW Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

NBSTW - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Newbury Street Acquisition?
El precio actual de las acciones de Newbury Street Acquisition es US$ 0.08
¿Cuántas acciones de Newbury Street Acquisition están en circulación?
Newbury Street Acquisition tiene 6,625,408 acciones en circulación
¿Cuál es la capitalización de mercado de Newbury Street Acquisition?
La capitalización de mercado de Newbury Street Acquisition es USD 530.03k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Newbury Street Acquisition?
Newbury Street Acquisition ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Newbury Street Acquisition?
El ratio precio/beneficio de Newbury Street Acquisition es 744.52
¿Cuál es la moneda de reporte de Newbury Street Acquisition?
Newbury Street Acquisition presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Newbury Street Acquisition?
El último beneficio anual de Newbury Street Acquisition es USD 97k
¿Cuál es la dirección registrada de Newbury Street Acquisition?
La dirección registrada de Newbury Street Acquisition es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿En qué sector industrial opera Newbury Street Acquisition?
Newbury Street Acquisition opera en el sector BLANK CHECKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M
Zorax Zorax 3 minutos hace
Stupid Gets what Stupid Dose Kind of ironic isn't it, using the wrong word about stupidity? lmao.

But then again, this just shows the tower of stupidity of trolls. I'd say the first 78 floors are empty of intelligence and the final 22 floors are just pure evil.
TURCH TURCH 5 minutos hace
Im ready for your long term play find it 😁


Regards 
marcis marcis 6 minutos hace
Ok Orlando Taddeo and his management is lying

Got it

Next
RDAR
skitahoe skitahoe 6 minutos hace
Market Beats article on AVXL

https://www.marketbeat.com/originals/short-squeeze-target-anavex-life-sciences-gains-traction/

I don't think anyone here posted this, it's complementary, but they're also pushing other stocks if you follow their link, which I didn't. I beli
AVXL JPM
JamesF1 JamesF1 7 minutos hace
Nasrat said on the last conference call that Elite sold their entire quota of Adderall. We don’t know if/when they obtained more quota. If they lost some market share on Adderall that is why. Vyvanse sales will almost all be in the current quarter, so February’s numbers MIGHT not be as impressiv
ELTP
jcromeenes jcromeenes 7 minutos hace
Yet January 16 looks to the the "exciting" day 😀
FNMA
John Doe 2024 John Doe 2024 7 minutos hace
It's none of their business what you funded or not. We can agree or disagree and argue on here but that's nobody's business but yours.
XERI
mineanddine mineanddine 7 minutos hace
Noting that HIRU is a confirmed scam 
HIRU
surfkast surfkast 8 minutos hace
Obviously you did not even read the website. SMH
HMBL
BDEZ BDEZ 8 minutos hace
Exactly, wonder if that can be overturned by Executive order?
Samuel J Samuel J 8 minutos hace
One more thing Mr. PROBLEM with the none stop Calandar, tell me one CEO that is in the OTC that communicates as much as Josh, with a ticket on NASDAQ and a few in the OTC? 

Name me one ☝️ 

Laughable!
AZRH
FOFreddie FOFreddie 9 minutos hace
HI Red Cloud - Take a look at the Warrant Agreement - personally I did not see an anti-dilution provision but not sure. You can access from the websites - I have previously posted them so perhaps others have access to the Agreements. It would seem that the biggest dilution risk comes with earli
DJT
mutant mutant 9 minutos hace
dear friends , thank you for post #60,508 [ as if, in anothers voicer: i already told you one time , 408/340 'it was half sided and not fair' ]. i rely on the uwbkq board deputies to delete my post if it contains text which is inappropropriate . i make no movie recommendations and i a
Mr Stockboy Mr Stockboy 10 minutos hace
Not only is Denner an insider, he and through Sarissa buy ailing firms and invest for greatness on a BO.

I think the pps will rise in the first quarter over $1 simply because the reality of a BO is real. At this point, neither France nor Germany will subvert the BO end game. I still
AMRN
Jack_Herer Jack_Herer 10 minutos hace
Go to MRT’s map portal and open the strategic prospectivity zone layer (if you can) and you will see these zones cover almost all of Tas. Not a very special designation, is it??

As for ‘proven resources’; without a full blown published 43-101 or JORC MRE, there is nothing ‘proven’.
MRT
Monksdream Monksdream 10 minutos hace
BFRG
BullFrog AI Holdings, Inc. is a digital biopharmaceutical company, which engages in artificial intelligence and machine learning driven analysis of complex data sets in medicine and healthcare. The company was founded by Vininder Singh in August 2017 and is headquartered in Gaithersburg,
BFRG
barnyarddog barnyarddog 11 minutos hace
https://www.kneron.com/

edge AI
SPKL
barnyarddog barnyarddog 12 minutos hace
Spark I Acquisition Eyes Merger with Kneron Holdings
TipRanks
October 22, 2024
https://finance.yahoo.com/news/spark-acquisition-eyes-merger-kneron-102725513.html
SPKL
Samuel J Samuel J 12 minutos hace
Look who is talking!

Now that's funny 😄 
AZRH
Involuntary-Recluse Involuntary-Recluse 13 minutos hace
IMHO absolutely buy buy buy :-)
CLHI
barnyarddog barnyarddog 13 minutos hace
Kneron, Inc. signed a letter of intent to acquire Spark I Acquisition Corporation in a reverse merger transaction.

October 20, 2024
https://www.marketscreener.com/quote/stock/SPARK-I-ACQUISITION-CORPO-162328222/news/Kneron-Inc-signed-a-letter-of-intent-to-acquire-Spark-I-Acqu
SPKL
Monksdream Monksdream 13 minutos hace
VTGN
Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for
VTGN

Su Consulta Reciente

Delayed Upgrade Clock